Patient Story
It was 2018. Woodcutting was a regular part of his routine, but today he could barely finish.
After a few tests at the hospital, he received a hard diagnosis. He had stage IV colorectal cancer — the second most common cause of cancer deaths worldwide.
His five-year chance of survival was only 15%.
Trevor was devastated.
He wanted to be around for his wife and daughters for years to come.
So he pursued the best treatments he could and started to attend group counseling. That’s where things started to turn around.
He realized he wanted to help other cancer patients like him. He started an online community, which grew into a nationwide nonprofit.
Since his diagnosis, Trevor has defied the odds. He’s had seven abdominal surgeries, undergone many rounds of chemotherapy and participated in a clinical trial. Now he’s on immunotherapy.
He’s living his life to the fullest, spending time with his family, advocating for patients and helping Parexel better understand how to meet the needs of cancer patients like him.
Lives can change when you design oncology trials with speed and precision.
- Utilize the right experts, with the right specialization
- Find the patients you need and earn their trust
- Satisfy global regulations to get your treatment to patients safely and quickly
- Design studies and endpoints with market access in mind
What we do, we do
OUR EXPERTS
Our oncology experts collaborate to get your treatment to patients faster.
OUR EXPERTS
Heidi Cho, MD
Vice President and Franchise Head – Hematology and Oncology
Heidi is a hematology and oncology drug development leader with more than 16 years of experience across hospital and CRO settings. She partners with sponsors to design and execute complex global trials with scientific rigor and operational precision. With deep expertise in hematology and advanced therapy programs, Heidi leads a global team of medical and scientific experts supporting clinical development strategy and helping bring innovative therapies to patients more efficiently.
"As trials become more complex, the best designs are the ones grounded in real-world insights and patient perspectives."
Our global oncology staff is 8,000+ strong, with experience across all tumor types and the development continuum to match the needs of your trial.
Advanced modeling and simulation allow us to predict drug effects ahead of time, saving time, money, and resources.
Our experience with oncology clinical trial sites around the world allows us to accelerate study start-up.
- North America
- South America
- Europe
- APAC
- Middle East & Africa
Our application of real-world data allows us to find the right study participants fast.
Our global regulatory team keeps everything running smoothly.
And our patient-first approach results in deeper, more relevant insights for trial design and execution.
TACTICS
BENEFITS MAY INCLUDE
We focus on patients, because they inspire us to deliver better clinical trials, faster than ever. So we can make a difference for more patients like Trevor.
What can we do to help you change patient lives?
Oncology capabilities All therapeutic areas Explore oncology careers
Who we are,
Parexel is proudly among the world’s largest
clinical research organizations
A dedicated CRO providing the full range of Phase I to IV clinical development services and leveraging the breadth of our clinical, regulatory and therapeutic expertise, our team of more than 24,000 global professionals works in partnership with biopharmaceutical leaders and sites to design and deliver clinical trials with patients in mind, to make clinical research a care option for anyone, anywhere.